Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $132,366.00 |
|---|---|
| Enterprise Value | $13.32 Million |
| Earnings per Share | $-0.03 |
| Beta | -0.21 |
| Outstanding Shares | 132,366,120 |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 35.16 |
| Enterprise Value to EBIT | -2.27 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -0.7 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective progr...